# Horizon Technology Finance Corp: overview

HRZN · Nasdaq · CIK 1487428 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hrzn.md) · [Financials](/companies/hrzn/financials.md) · [Filings](/companies/hrzn/filings.md) · [Insiders](/companies/hrzn/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.20](/filings/0001437749-25-031988.md) | not reported | [(0.53)](/filings/0001437749-26-014916.md) | [(0.50)](/filings/0001437749-26-025689.md) | [0.68](/filings/0001437749-25-031988.md) | not reported | [0.06](/filings/0001437749-26-014916.md) | [(0.57)](/filings/0001437749-26-025689.md) |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | not reported | [0.86](/filings/0001437749-25-006114.md) | [(0.56)](/filings/0001437749-26-006636.md) | [(0.16)](/filings/0001437749-26-006636.md) | [(0.06)](/filings/0001437749-26-006636.md) |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hrzn/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $5.0m | 1,055,591 |  | Added +1,008,154 |
| [Bulldog Investors, LLP](/funds/1504304.md) | 2026-06-30 | $3.1m | 658,617 |  | New +658,617 |
| [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $2.8m | 592,247 |  | Added +420,469 |
| [Caprock Group, LLC](/funds/1610769.md) | 2026-06-30 | $2.2m | 454,442 |  | New +454,442 |
| [Green Alpha Advisors, LLC](/funds/1439207.md) | 2026-06-30 | $2.0m | 429,913 |  | Reduced −160,228 |
| [Legal & General Group Plc](/funds/764068.md) | 2026-06-30 | $1.8m | 386,211 |  | Added +57,556 |
| [Eagle Point Credit Management LLC](/funds/1607203.md) | 2026-06-30 | $1.7m | 366,194 |  | Unchanged |
| [Virtus Investment Advisers, LLC](/funds/19481.md) | 2026-06-30 | $1.2m | 252,455 |  | Added +108,487 |
| [BLAIR WILLIAM & CO/IL](/funds/902367.md) | 2026-06-30 | $1.1m | 239,073 |  | New +239,073 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $1.1m | 225,732 |  | Added +164,779 |

## Recent filings

[All 788 filings](/companies/hrzn/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-09 | 16:05 ET | [8-K](/filings/0001437749-26-029978.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-029978 |
| 2026-08-04 | 16:54 ET | [8-K](/filings/0001437749-26-025691.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-025691 |
| 2026-08-04 | 16:53 ET | [10-Q](/filings/0001437749-26-025689.md) | Quarterly report, period 2026-06-30 | 0001437749-26-025689 |
| 2026-08-04 | 16:52 ET | [8-K](/filings/0001437749-26-025688.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-025688 |
| 2026-06-26 | 16:35 ET | [8-K](/filings/0001437749-26-021848.md) | 5.07 Shareholder vote results | 0001437749-26-021848 |
| 2026-05-14 | 16:32 ET | [8-K](/filings/0001437749-26-017078.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-26-017078 |
| 2026-05-14 | 08:57 ET | [DEF 14A](/filings/0001437749-26-016896.md) | Proxy statement, period 2026-06-26 | 0001437749-26-016896 |
| 2026-05-05 | 16:38 ET | [10-Q](/filings/0001437749-26-014916.md) | Quarterly report, period 2026-03-31 | 0001437749-26-014916 |
| 2026-05-05 | 16:28 ET | [8-K](/filings/0001437749-26-014895.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-014895 |
| 2026-05-05 | 16:26 ET | [8-K](/filings/0001437749-26-014892.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-014892 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-006636.md), filed Mar 3, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1487428
- Tickers: HRZN, HTFC
- Exchange: Nasdaq
- SIC code: not reported
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.